Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
View Session ViewAttendees 26
Symposium

30 - The Ongoing Battle of SARS-CoV-2 and the Human Immune System

Thursday, September 30, 2021
12:30 PM - 1:45 PM EDT

    Moderator(s)

  • Anne-Catrin Uhlemann, MD, PhD

    Associate Professor
    Medicine/Infectious Diseases
    Columbia University Irving Medical Center
    New York, NY, United States

    Merck (Individual(s) Involved: Self): Grant/Research Support

  • Michael Glickman, MD, FIDSA, FAAM

    Member, Attending Physician
    Memorial Sloan Kettering
    New York, NY, United States

    Fimbrion Therapeutics (Individual(s) Involved: Self): Consultant; Pathogen Response Lab (Individual(s) Involved: Self): Board Member; Vedanta Biosciences (Individual(s) Involved: Self): Board Member, Shareholder

    • Speaker(s)

  • Qian Zhang, MD

    Research Associate
    Rockefeller University

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • David Ho, MD

    Director, Aaron Diamond AIDS Research Center, Professor of Medicine
    Columbia University Vagelos College of Physicians and Surgeons
    New York, NY, United States

    Brii Biosciences (Individual(s) Involved: Self): Consultant; Merck (Individual(s) Involved: Self): Research Grant or Support; RenBio (Individual(s) Involved: Self): Consultant, Founder, Other Financial or Material Support, Shareholder; WuXi Biologics (Individual(s) Involved: Self): Consultant

  • Jennifer Dan, MD, PhD

    Assistant Professor
    UCSD

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:
Anne-Catrin Uhlemann, MD, PhD: Merck (Individual(s) Involved: Self): Grant/Research Support
Michael S. Glickman, MD, FIDSA, FAAM: Fimbrion Therapeutics (Individual(s) Involved: Self): Consultant; Pathogen Response Lab (Individual(s) Involved: Self): Board Member; Vedanta Biosciences (Individual(s) Involved: Self): Board Member, Shareholder
Qian Zhang, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
David D. Ho, MD: Brii Biosciences (Individual(s) Involved: Self): Consultant; Merck (Individual(s) Involved: Self): Research Grant or Support; RenBio (Individual(s) Involved: Self): Consultant, Founder, Other Financial or Material Support, Shareholder; WuXi Biologics (Individual(s) Involved: Self): Consultant
Jennifer Dan, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • describe the interaction of key epitopes in SARS-CoV-2 with human antiobodies
  • explain the role of the cellular immune response in SARS-CoV-2 infection
  • desribe host-bacterial interactions in SARS-CoV-2 infection

Presentations:

  • Autoantibodies against type I IFNs account for ~20% of COVID death

    Speaker: Qian Zhang, MD – Rockefeller University

  • Escape of sars-cov-2 Variants from Natural and Vaccine Induced Immunity

    Speaker: David D. Ho, MD – Columbia University Vagelos College of Physicians and Surgeons

  • Immunological Memory to sars-cov-2

    Speaker: Jennifer Dan, MD, PhD – UCSD